Use of the Venous Coupler in Breast Reconstruction by Means of a Deep Inferior Epigastric Perforator: Reduction of Surgery Length and Venous Thromboses ?

May 30, 2018 updated by: Socorro ORTIZ, Brugmann University Hospital
This is a retrospective study performed on medical records, in order to compare the number of venous thromboses, the surgery duration, the complications rate and the duration of anastomosis in breast reconstructive surgeries by the DIEP (Deep Inferior Epigastric Perforator Flap) technique, with or without the use of a venous coupler.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Breast cancer is the most common and deadliest cancer among women in Belgium. Women with invasive cancer may be offered a total mastectomy with or without adjuvant/neoadjuvant therapy, and with or without breast reconstruction. It is obvious that the loss of a breast can impact the self-image, hence the importance of informing the patient about the possibilities of breast reconstruction. Between 14 and 20% of women choose to resort to reconstruction.

Different types of breast reconstruction exist: prosthetic reconstruction, lipolifting and flap reconstruction (of large dorsal, gluteus maximus, rectus abdominis muscle and "DIEP").

DIEP (Deep Inferior Epigastric Perforator Flap) presents numerous advantages. It consists in the use of a free cutaneo-greasy flap taken from the abdomen, without muscle removed. The abdominal skin has a similar appearance to the breast skin and, thanks to the presence of fat, the missing volume is replaced by a living tissue. Weakness of the abdominal wall is also avoided. However, it remains a surgical procedure with possible complications.

There are several steps in this surgery. The first is to dissect the abdominal flap by talking the skin and subcutaneous fat and isolating one or two branches of the lower epigastric artery and one or two veins. The donor area is then closed. The second step is to prepare the recipient area, ie dissect the artery that will be anastomosed with the lower deep epigastric artery.This artery can be the intern mammary artery, the thoraco-dorsal artery or more rarely the axillary artery. The third step consists of performing arterial and venous anastomoses and checking the quality of these.

Two microanastomoses must thus be performed: arterial and venous. The classic technique, the most used, is to suture the 2 veins. Alternatively, a coupler device can be used to perform the venous anastomosis.

It is therefore interesting to compare the classical method and the venous coupler method in terms of surgery duration, venous thrombosis and complications. If the coupler is proved effective, it could replace the manual suture.

Venous thrombosis is the main cause of flap failure. But surgery duration has also an impact on the complication rate, and the anastomosis duration corresponds to the time during which the flap is not perfused. It is thus necessary to keep it to a minimum in order to reduce the risk of flap loss.

Study Type

Observational

Enrollment (Actual)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brussels, Belgium, 1020
        • CHU Brugmann

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Women having had a total mastectomy and a mammary reconstruction by the DIEP technique with or without venous coupler utilisation, treated within the CHU Brugmann hospital between 01/01/2017 and 01/09/2017.

Description

Inclusion Criteria:

  • Total mastectomy with mammary reconstruction by the DIEP technique
  • Patients treated within the CHU Brugmann Hospital
  • Patients treated between 01/01/2017 and 01/09/2017

Exclusion Criteria:

/

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Mammary reconstruction by DIEP with venous coupler
A coupler can be used to perform a venous anastomosis. It is a double ring with pins on only one of its 2 faces. The technique consists in clamping the two veins, estimating the intima-to-intimal diameter of the vessels, choosing the coupler of the appropriate size, sliding the vein in the ring and evers the edges of the vessel to fix them on the pins, redo the same thing for the other vein and finally bring the two vessels together in order to clip them together.
Mammary reconstruction by DIEP without venous coupler

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of venous thrombosis
Time Frame: Up to 1 week after mammary reconstruction surgery
Rate of venous thrombosis
Up to 1 week after mammary reconstruction surgery
Surgery duration
Time Frame: At the date of mammary reconstruction surgery.
Duration of the mammary reconstruction surgery with the DIEP technique
At the date of mammary reconstruction surgery.
Anastomosis duration
Time Frame: At the date of mammary reconstruction surgery.
Duration of the anastomosis during the mammary reconstruction surgery
At the date of mammary reconstruction surgery.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Age
Time Frame: At the date of mammary reconstruction surgery.
Patient age
At the date of mammary reconstruction surgery.
Body mass index
Time Frame: At the date of mammary reconstruction surgery.
Body mass index
At the date of mammary reconstruction surgery.
Tabagism
Time Frame: At the date of mammary reconstruction surgery.
Tabagism status (smoker/non smoker)
At the date of mammary reconstruction surgery.
Co-morbidity : diabetes
Time Frame: At the date of mammary reconstruction surgery.
Medical history of diabetes
At the date of mammary reconstruction surgery.
Co-morbidity : cardio-vascular disease
Time Frame: At the date of mammary reconstruction surgery.
Medical history of cardio-vascular disease
At the date of mammary reconstruction surgery.
Co-morbidity : medical history of venous thrombosis
Time Frame: At the date of mammary reconstruction surgery.
Medical history of venous thrombosis
At the date of mammary reconstruction surgery.
Immediate of differed reconstruction
Time Frame: At the date of mammary reconstruction surgery.
Reconstruction performed immediately after mastectomy or not
At the date of mammary reconstruction surgery.
Unilateral or Bilateral DIEP
Time Frame: At the date of mammary reconstruction surgery.
Unilateral or Bilateral DIEP
At the date of mammary reconstruction surgery.
Medical complications (yes/no)
Time Frame: Up to one week after mammary reconstruction surgery
Medical complications within the grafted flap
Up to one week after mammary reconstruction surgery
Type of cancer treatment
Time Frame: At the date of mammary reconstruction surgery.
(neo)adjuvant chemiotherapy or (neo)adjuvant radiotherapy
At the date of mammary reconstruction surgery.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Claudia Miszewska, MD, CHU Brugmann

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2017

Primary Completion (Actual)

May 28, 2018

Study Completion (Actual)

May 28, 2018

Study Registration Dates

First Submitted

November 9, 2017

First Submitted That Met QC Criteria

November 9, 2017

First Posted (Actual)

November 13, 2017

Study Record Updates

Last Update Posted (Actual)

May 31, 2018

Last Update Submitted That Met QC Criteria

May 30, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • CHUB-venous coupler

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mammary Reconstruction

Clinical Trials on Venous coupler

Subscribe